These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 7763744)
21. Prediction of accumulation of 131I-labelled meta-iodobenzylguanidine in neuroblastoma cell lines by means of reverse transcription and polymerase chain reaction. Mairs RJ; Livingstone A; Gaze MN; Wheldon TE; Barrett A Br J Cancer; 1994 Jul; 70(1):97-101. PubMed ID: 7517173 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and efficacy of 131I-meta-iodobenzylguanidine in two neuroblastoma xenografts. Gaze MN; Hamilton TG; Mairs RJ Br J Radiol; 1994 Jun; 67(798):573-8. PubMed ID: 8032811 [TBL] [Abstract][Full Text] [Related]
23. Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH. Buck J; Bruchelt G; Girgert R; Treuner J; Niethammer D Cancer Res; 1985 Dec; 45(12 Pt 1):6366-70. PubMed ID: 3864530 [TBL] [Abstract][Full Text] [Related]
26. HBO and the uptake and retention of [125I] MIBG in human platelets and two neuroendocrine cell lines. Tytgat GA; Cornelissen J; Van den Brug M; Van Kuilenburg AB; Voute PA; Van der Kleij AJ; Van Gennip AH Anticancer Res; 1997; 17(2A):1209-12. PubMed ID: 9137473 [TBL] [Abstract][Full Text] [Related]
27. [Intracellular uptake and accumulation of metaiodobenzylguanidine in neuroblastoma cells and small cell carcinoma of the lung]. Melino G Minerva Pediatr; 1989 Mar; 41(3):123-8. PubMed ID: 2546031 [TBL] [Abstract][Full Text] [Related]
28. Enhanced tumour uptake and in vitro radiotoxicity of no-carrier-added [131I]meta-iodobenzylguanidine: implications for the targeted radiotherapy of neuroblastoma. Mairs RJ; Russell J; Cunningham S; O'Donoghue JA; Gaze MN; Owens J; Vaidyanathan G; Zalutsky MR Eur J Cancer; 1995; 31A(4):576-81. PubMed ID: 7576972 [TBL] [Abstract][Full Text] [Related]
29. [131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects. Klingebiel T; Treuner J; Ehninger G; Keller KD; Dopfer R; Feine U; Niethammer D Cancer Chemother Pharmacol; 1989; 25(2):143-8. PubMed ID: 2598401 [TBL] [Abstract][Full Text] [Related]
30. Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells. Bayer M; Kuçi Z; Schömig E; Gründemann D; Dittmann H; Handgretinger R; Bruchelt G Nucl Med Biol; 2009 Apr; 36(3):287-94. PubMed ID: 19324274 [TBL] [Abstract][Full Text] [Related]
31. [131I]MIBG as a first line treatment in advanced neuroblastoma. Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752 [TBL] [Abstract][Full Text] [Related]
32. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy. Mastrangelo S; Tornesello A; Diociaiuti L; Pession A; Prete A; Rufini V; Troncone L; Mastrangelo R Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic use of I-131-MIBG in nude mice hosting human neuroblastoma xenografts. Senekowitsch R; Laubenbacher C; Möllenstädt S; Kriegel H; Pabst HW Strahlenther Onkol; 1989 Jul; 165(7):566-8. PubMed ID: 2749502 [No Abstract] [Full Text] [Related]
34. Release mechanisms of [125I]meta-iodobenzylguanidine in neuroblastoma cells: evidence of a carrier-mediated efflux. Servidei T; Iavarone A; Lasorella A; Mastrangelo S; Riccardi R Eur J Cancer; 1995; 31A(4):591-5. PubMed ID: 7576975 [TBL] [Abstract][Full Text] [Related]
35. Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB. Yang X; Merchant MS; Romero ME; Tsokos M; Wexler LH; Kontny U; Mackall CL; Thiele CJ Cancer Res; 2003 Mar; 63(5):1122-9. PubMed ID: 12615731 [TBL] [Abstract][Full Text] [Related]
36. Effect of adrenergic receptor ligands on metaiodobenzylguanidine uptake and storage in neuroblastoma cells. Babich JW; Graham W; Fischman AJ Eur J Nucl Med; 1997 May; 24(5):538-43. PubMed ID: 9142735 [TBL] [Abstract][Full Text] [Related]
37. Session on the biology and treatment of neuroblastoma as related to metaiodobenzylguanidine. Chairmen's report. Sisson JC; De Bernardi B J Nucl Biol Med (1991); 1991; 35(4):199-201. PubMed ID: 1823818 [No Abstract] [Full Text] [Related]
38. Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors. Carlin S; Mairs RJ; McCluskey AG; Tweddle DA; Sprigg A; Estlin C; Board J; George RE; Ellershaw C; Pearson AD; Lunec J; Montaldo PG; Ponzoni M; van Eck-Smit BL; Hoefnagel CA; van den Brug MD; Tytgat GA; Caron HN Clin Cancer Res; 2003 Aug; 9(9):3338-44. PubMed ID: 12960120 [TBL] [Abstract][Full Text] [Related]
39. 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes. Gaze MN; Mairs RJ; Boyack SM; Wheldon TE; Barrett A Br J Cancer; 1992 Dec; 66(6):1048-52. PubMed ID: 1457344 [TBL] [Abstract][Full Text] [Related]